Prot #M15-410: A Randomized, Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without Ribavirin in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection wh

Project: Research project

Project Details

StatusFinished
Effective start/end date8/6/158/6/18

Funding

  • AbbVie Inc. (Prot #M15-410)